A coronavirus vaccine will likely be available in the United States by the end of the second week of December, Centers for Disease Control and Prevention director Robert Redfield said on Tuesday.
Redfield said Fox News‘ The daily briefing that the vaccine would be made available “in a hierarchical manner” that would prioritize “residents of nursing homes and then to a mix of health care providers and people at high risk of poor outcomes.”
The Food and Drug Administration (FDA) will hold a meeting on December 10 of its Vaccines and Related Biologics Advisory Committee to review Pfizer’s Emergency Use Authorization (EUA) application for its vaccine candidate, which drug maker and German partner BioNTech announced last week. 95 percent effective.
“I think we’ll have about 40 million doses of vaccine by the end of… the year,” Redfield said. “This is enough to vaccinate 20 million people. But then it will continue until January and February and hopefully by March we will start to see the vaccine available to the general public. “
Pfizer is one of three promising vaccine candidates; Moderna and AstraZeneca reported that their vaccine candidates are 94.5% effective and 90% effective, respectively. Moderna said last week its intention to submit an EUA application to the FDA “in the coming weeks.”
Redfield, while acknowledging that “it is exceptional that we have these vaccines and very exciting, ”urged Americans to continue taking precautions to mitigate the spread of the virus.
“I want people to be vigilant because we are turning the corner now,” he said. “You don’t want to be the last group to end up getting COVID.”